Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Common side effects associated with retatrutide consistent with the broader GLP-1 receptor agonist class, as described in the Summary of Product Characteristics (SmPC) for licensed medicines such as Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide) include: Nausea (particularly during dose escalation) Vomiting Diarrhoea or constipation Decreased appetite Injection site reactions such as mild redness or discomfort Increased heart rate , which has been observed with incretin-based therapies These gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts
Practical Steps to Consider The following actionable steps will help you understand how genetic testing can enhance your diabetes management
Combining incretin-based drugs and RAAS inhibitors: more cons than pros
What should a person expect when beginning treatment and over the long term
Because both substances affect blood sugar and digestion, taking them together can lead to an additive effect
US$ 22.70
US$ 21.42
US$ 21.94
US$ 21.04
US$ 22.74
US$ 25.96
US$ 27.86
US$ 21.69
US$ 23.99
US$ 25.09
US$ 28.59
